Compliance and Administration Technique in Topical Drug Therapy of Glaucoma

• Sponsor: University of Toronto (Other)
• Overall Status: Completed
• CT.gov ID: NCT00303121
• Collaborator: (none)
• Enrollment: 120
• Location: 1
• Duration (Months): 7
• Patients Per Site Per Month: 17.2

Study Details

Study Description

Brief Summary

Clinic-based evaluation of patients compliance with topical medications in the treatment of glaucoma. Also assessing effectiveness of delivery techniques among these patients.

Condition or Disease	Intervention/Treatment	Phase
Glaucoma

Study Design

• Study Type: Observational
• Observational Model: Defined Population
• Time Perspective: Other
• Study Start Date: Nov 1, 2005
• Study Completion Date: Jun 1, 2006

Outcome Measures

Primary Outcome Measures

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

glaucoma 18 years of age or older

Exclusion Criteria:

Recent ocular surgery

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Toronto Western Hospital	Toronto	Ontario	Canada	M5T 2S8

Sponsors and Collaborators

• University of Toronto

Investigators

• Principal Investigator: Yvonne M Buys, MD, University of Toronto

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• ClinicalTrials.gov Identifier: NCT00303121
• Other Study ID Numbers: UHN REB 05-0631-AE
• First Posted: Mar 15, 2006
• Last Update Posted: Oct 11, 2006
• Last Verified: Jun 1, 2006

• Keywords provided by , ,: Glaucoma; Compliance; Therapy; Administration technique
• Additional relevant MeSH terms: Glaucoma

Study Results

No Results Posted as of Oct 11, 2006